Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Aethlon Medical (AEMD) Shares Outstanding (Diluted Average) (2021 - 2024)

Aethlon Medical (AEMD) has disclosed Shares Outstanding (Diluted Average) for 5 consecutive years, with $147520.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Shares Outstanding (Diluted Average) fell 94.14% year-over-year to $147520.0, compared with a TTM value of $147520.0 through Dec 2024, down 94.14%, and an annual FY2024 reading of $314097.0, down 84.71% over the prior year.
  • Shares Outstanding (Diluted Average) was $147520.0 for Q4 2024 at Aethlon Medical, up from $133944.0 in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $15.5 million in Q2 2022 and bottomed at $133944.0 in Q3 2024.
  • Average Shares Outstanding (Diluted Average) over 4 years is $5.8 million, with a median of $2.4 million recorded in 2023.
  • The sharpest move saw Shares Outstanding (Diluted Average) surged 35.56% in 2023, then crashed 94.55% in 2024.
  • Year by year, Shares Outstanding (Diluted Average) stood at $15.4 million in 2021, then plummeted by 87.18% to $2.0 million in 2022, then grew by 27.47% to $2.5 million in 2023, then plummeted by 94.14% to $147520.0 in 2024.
  • Business Quant data shows Shares Outstanding (Diluted Average) for AEMD at $147520.0 in Q4 2024, $133944.0 in Q3 2024, and $932248.0 in Q2 2024.